Skip to main content
June 13, 2012
Source - Xconomy.com
Doug Hawkins, the associate division chief for hematology/oncology at Seattle Children’s Hospital, says genome sequencing in its current form “is an incredibly powerful tool” for generating new data about the biology of health and disease, but careful studies will need to be done before it can provide a reliable guide for physician decision making.
If you have not worked with Seattle Children’s before, please read our press policy before contacting us.
The best way to reach the public relations team is via email at email@example.com. This inbox is monitored seven days a week, during and after business hours, on weekends and on holidays.
Phone: 206-987-4500(8:30 a.m. to 5:30 p.m. Pacific time, Monday–Friday only)
Note: This contact information is for members of the media only. For general hospital or research questions, please call the hospital switchboard at 206-987-2000.
Measles, mumps and whooping cough have been around a long time – along with the vaccines to prevent them. But instead of being ... cont.
A new study from Seattle Children’s Research Institute suggests integrating mental health treatment into primary care may ... cont.
Researchers at Seattle Children’s Research Institute have pinpointed a tiny area of the brain that controls our motivation to ... cont.
Seattle Children’s provides healthcare without regard to race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry) or disability. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.
© 1995-2014 Seattle Children’s Hospital